test

Sean Tan

@Stempoint Capital Lp

Latest period2024 - Q3ReportedManaged Assets$334.017MTotal holdings50
Assets growth rate-1.84%Assets growth rate (2-Q avg)-5.94%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Stempoint Capital Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 50 positions.

Assets under management

The assets under management (AUM) of Stempoint Capital Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 334.017M in assets, with a quarterly growth rate of -1.84% and a 2-quarter average growth rate of -5.94%. The portfolio is managed by Sean Tan, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BMYBristol-myers Squibb Co
Recent Activity
New Position
4.27%
$14.244M
275,303 shares@ $51.74 avg price
INCYIncyte Corp
Recent Activity
New Position
2.57%
$8.559M
129,490 shares@ $66.1 avg price
DAWNDay One Biopharmaceuticals I
Recent Activity
New Position
2.12%
$7.062M
506,978 shares@ $13.94 avg price
SLRNAcelyrin Inc
Recent Activity
New Position
1.95%
$6.497M
1.318M shares@ $4.93 avg price
SLNOSoleno Therapeutics Inc
Recent Activity
New Position
1.87%
$6.219M
123,177 shares@ $50.5 avg price
KROSKeros Therapeutics Inc
Recent Activity
New Position
1.52%
$5.048M
86,930 shares@ $58.07 avg price
ZURAZura Bio Ltd
Recent Activity
New Position
1.27%
$4.239M
1.044M shares@ $4.06 avg price
TERNTerns Pharmaceuticals Inc
Recent Activity
New Position
1.13%
$3.747M
449,321 shares@ $8.34 avg price
URGNUrogen Pharma Ltd
Recent Activity
New Position
0.93%
$3.073M
241,984 shares@ $12.71 avg price
WVEWave Life Sciences Ltd
Recent Activity
New Position
0.74%
$2.46M
300,000 shares@ $8.2 avg price